There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble

There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble

Immunohistochemistry is a powerful tool for the diagnosis and subclassification of hematolymphoid neoplasms. However, the expression of certain markers is not always as expected, and unusual patterns of staining can lead to misdiagnosis. CD20 and CD3 are our most commonly used markers for identifica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in anatomic pathology 2018-01, Vol.25 (1), p.14-23
1. Verfasser: Ferry, Judith A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23
container_issue 1
container_start_page 14
container_title Advances in anatomic pathology
container_volume 25
creator Ferry, Judith A
description Immunohistochemistry is a powerful tool for the diagnosis and subclassification of hematolymphoid neoplasms. However, the expression of certain markers is not always as expected, and unusual patterns of staining can lead to misdiagnosis. CD20 and CD3 are our most commonly used markers for identification of B cells and T cells, respectively, and they almost always yield reliable, specific staining. This discussion focuses on diagnostic pitfalls related to the use of immunohistochemistry for CD20 and CD3 in hematopathology, and specifically on diagnostic challenges that arise when (1) CD20 is not expressed in B-cell lymphomas, when (2) CD20 is expressed in plasma cell neoplasms and T-cell lymphomas, and when (3) CD3 is expressed in B-cell lymphomas and Hodgkin lymphoma.
doi_str_mv 10.1097/PAP.0000000000000174
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1940055910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1940055910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3564-21ff6fdea1c9e3afd37f56f13426222972703fd9da1399cb683235238f94af343</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0E4lH4Bwj5yCXFryQ1t1KgVOJ1KAdOkZus24ATF9sB9d9j1IIQB1Za7Ry-mZUGoWNK-pTI_Oxx-Ngnv4fmYgvt05TzRBBOt6MmOUtEpPfQgfcvEWF5RnfRHhtIKjIq99HLdAEO8DDuvcV3al6X-KIzBoLHdYtvoFHBLlVYWGPnq3N89Q4tnjRN11ofVN16rK3Do0tGsGqrKDgeqRaPIeBn2-FJGyyeOtvNDByiHa2Mh6PN7aGn66vp6Ca5fRhPRsPbpORpJhJGtc50BYqWErjSFc91mmnKBcsYYzJnOeG6kpWiXMpylg044ynjAy2F0lzwHjpd5y6dfevAh6KpfQnGqBZs5wsqBSFpKimJqFijpbPeO9DF0tWNcquCkuKr5SK2XPxtOdpONh-6WQPVj-m71ggM1sCHNQGcfzXdB7hiAcqExf_Zn5b6hh0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1940055910</pqid></control><display><type>article</type><title>There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble</title><source>Journals@Ovid Complete</source><creator>Ferry, Judith A</creator><creatorcontrib>Ferry, Judith A</creatorcontrib><description>Immunohistochemistry is a powerful tool for the diagnosis and subclassification of hematolymphoid neoplasms. However, the expression of certain markers is not always as expected, and unusual patterns of staining can lead to misdiagnosis. CD20 and CD3 are our most commonly used markers for identification of B cells and T cells, respectively, and they almost always yield reliable, specific staining. This discussion focuses on diagnostic pitfalls related to the use of immunohistochemistry for CD20 and CD3 in hematopathology, and specifically on diagnostic challenges that arise when (1) CD20 is not expressed in B-cell lymphomas, when (2) CD20 is expressed in plasma cell neoplasms and T-cell lymphomas, and when (3) CD3 is expressed in B-cell lymphomas and Hodgkin lymphoma.</description><identifier>ISSN: 1072-4109</identifier><identifier>EISSN: 1533-4031</identifier><identifier>DOI: 10.1097/PAP.0000000000000174</identifier><identifier>PMID: 28914619</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><ispartof>Advances in anatomic pathology, 2018-01, Vol.25 (1), p.14-23</ispartof><rights>Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3564-21ff6fdea1c9e3afd37f56f13426222972703fd9da1399cb683235238f94af343</citedby><cites>FETCH-LOGICAL-c3564-21ff6fdea1c9e3afd37f56f13426222972703fd9da1399cb683235238f94af343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28914619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferry, Judith A</creatorcontrib><title>There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble</title><title>Advances in anatomic pathology</title><addtitle>Adv Anat Pathol</addtitle><description>Immunohistochemistry is a powerful tool for the diagnosis and subclassification of hematolymphoid neoplasms. However, the expression of certain markers is not always as expected, and unusual patterns of staining can lead to misdiagnosis. CD20 and CD3 are our most commonly used markers for identification of B cells and T cells, respectively, and they almost always yield reliable, specific staining. This discussion focuses on diagnostic pitfalls related to the use of immunohistochemistry for CD20 and CD3 in hematopathology, and specifically on diagnostic challenges that arise when (1) CD20 is not expressed in B-cell lymphomas, when (2) CD20 is expressed in plasma cell neoplasms and T-cell lymphomas, and when (3) CD3 is expressed in B-cell lymphomas and Hodgkin lymphoma.</description><issn>1072-4109</issn><issn>1533-4031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0E4lH4Bwj5yCXFryQ1t1KgVOJ1KAdOkZus24ATF9sB9d9j1IIQB1Za7Ry-mZUGoWNK-pTI_Oxx-Ngnv4fmYgvt05TzRBBOt6MmOUtEpPfQgfcvEWF5RnfRHhtIKjIq99HLdAEO8DDuvcV3al6X-KIzBoLHdYtvoFHBLlVYWGPnq3N89Q4tnjRN11ofVN16rK3Do0tGsGqrKDgeqRaPIeBn2-FJGyyeOtvNDByiHa2Mh6PN7aGn66vp6Ca5fRhPRsPbpORpJhJGtc50BYqWErjSFc91mmnKBcsYYzJnOeG6kpWiXMpylg044ynjAy2F0lzwHjpd5y6dfevAh6KpfQnGqBZs5wsqBSFpKimJqFijpbPeO9DF0tWNcquCkuKr5SK2XPxtOdpONh-6WQPVj-m71ggM1sCHNQGcfzXdB7hiAcqExf_Zn5b6hh0</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Ferry, Judith A</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201801</creationdate><title>There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble</title><author>Ferry, Judith A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3564-21ff6fdea1c9e3afd37f56f13426222972703fd9da1399cb683235238f94af343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferry, Judith A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in anatomic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferry, Judith A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble</atitle><jtitle>Advances in anatomic pathology</jtitle><addtitle>Adv Anat Pathol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>25</volume><issue>1</issue><spage>14</spage><epage>23</epage><pages>14-23</pages><issn>1072-4109</issn><eissn>1533-4031</eissn><abstract>Immunohistochemistry is a powerful tool for the diagnosis and subclassification of hematolymphoid neoplasms. However, the expression of certain markers is not always as expected, and unusual patterns of staining can lead to misdiagnosis. CD20 and CD3 are our most commonly used markers for identification of B cells and T cells, respectively, and they almost always yield reliable, specific staining. This discussion focuses on diagnostic pitfalls related to the use of immunohistochemistry for CD20 and CD3 in hematopathology, and specifically on diagnostic challenges that arise when (1) CD20 is not expressed in B-cell lymphomas, when (2) CD20 is expressed in plasma cell neoplasms and T-cell lymphomas, and when (3) CD3 is expressed in B-cell lymphomas and Hodgkin lymphoma.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28914619</pmid><doi>10.1097/PAP.0000000000000174</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1072-4109
ispartof Advances in anatomic pathology, 2018-01, Vol.25 (1), p.14-23
issn 1072-4109
1533-4031
language eng
recordid cdi_proquest_miscellaneous_1940055910
source Journals@Ovid Complete
title There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T12%3A17%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=There%20Are%20No%20Magic%20Bullets%20in%20Hematopathology:%20Even%20Immunostains%20for%20CD20%20and%20CD3%20Can%20Get%20You%20Into%20Trouble&rft.jtitle=Advances%20in%20anatomic%20pathology&rft.au=Ferry,%20Judith%20A&rft.date=2018-01&rft.volume=25&rft.issue=1&rft.spage=14&rft.epage=23&rft.pages=14-23&rft.issn=1072-4109&rft.eissn=1533-4031&rft_id=info:doi/10.1097/PAP.0000000000000174&rft_dat=%3Cproquest_cross%3E1940055910%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1940055910&rft_id=info:pmid/28914619&rfr_iscdi=true